You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

iNHL

Showing 26 - 50 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (ZX-101A)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • Gilbert, Arizona
  • +5 more
Jan 14, 2022

Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 18, 2021

Recurrent Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Nodal Marginal Zone Lymphoma Trial (Acalabrutinib,

Withdrawn
  • Recurrent Follicular Lymphoma
  • +8 more
  • (no location specified)
Jun 2, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +23 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 23, 2022

Indolent Non-Hodgkin Lymphoma Trial in Worldwide (Duvelisib)

Active, not recruiting
Has Results
  • Indolent Non-Hodgkin Lymphoma
  • Los Angeles, California
  • +68 more
Mar 15, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mobile, Alabama
  • +120 more
Dec 20, 2019

Low-Grade B-cell Lymphoma Trial in New York (rhuFlt3L/CDX-301, Poly-ICLC)

Recruiting
  • Low-Grade B-cell Lymphoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 17, 2020

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

DLBCL, Lymphoma Follicular Trial in Australia, Italy, United States (Atezolizumab, Bendamustine, Cyclophosphamide)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma, Lymphoma Follicular
  • Aurora, Colorado
  • +20 more
Apr 26, 2021

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)

Completed
Has Results
  • Follicular Lymphoma
  • +3 more
  • Fullerton, California
  • +40 more
Jun 14, 2019

Indolent Non-Hodgkin's Lymphomas Trial in Worldwide (Placebo, Rituximab, Idelalisib)

Terminated
Has Results
  • Indolent Non-Hodgkin's Lymphomas
  • Placebo
  • +2 more
  • Huntsville, Alabama
  • +102 more
Oct 19, 2018

Indolent Non-Hodgkin's Lymphomas Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

Terminated
Has Results
  • Indolent Non-Hodgkin's Lymphomas
  • Huntsville, Alabama
  • +143 more
Oct 19, 2018

Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Palo Alto, New York (Idelalisib)

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +3 more
  • Palo Alto, California
  • +1 more
Oct 19, 2018

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in United States (Idelalisib, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Long Beach, California
  • +5 more
May 1, 2019

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Canada (Bendamustine at a dose of 100 mg/m2, Bendamustine

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • Chronic Lymphocytic Leukemia
  • Bendamustine at a dose of 100 mg/m2
  • Bendamustine at a dose of 120 mg/m2
  • Calgary, Alberta, Canada
  • +15 more
Jun 29, 2017

B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion Trial in Worldwide (Idelalisib, Rituximab)

Terminated
Has Results
  • B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion
  • Tucson, Arizona
  • +55 more
Oct 19, 2018

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Bendamustine, Rituximab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Fullerton, California
  • +90 more
Oct 19, 2018

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Chlorambucil, Obinutuzumab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Santa Barbara, California
  • +17 more
Oct 19, 2018

Chronic Lymphocytic Leukaemia Or Indolent Non Hodgkin's Lymphoma

Terminated
  • Indolent Non Hodgkin's Lymphoma (iNHL)
  • Chronic Lymphocytic Leukaemia (CLL)
    • Irbid, Jordan
    • +7 more
    Jun 17, 2016

    Lymphoma Trial in France, Germany (Obinutuzumab)

    Completed
    Has Results
    • Lymphoma
    • Creteil, France
    • +15 more
    Aug 18, 2016

    Diffuse Large B-cell Lymphoma, Indolent Non-hodgkin Lymphoma, Primary CNS Lymphoma Trial in France (Vismodegib)

    Terminated
    • Diffuse Large B-cell Lymphoma
    • +3 more
    • Creteil, France
    • +9 more
    Mar 8, 2017

    Indolent Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Aurora, Augusta, Charleston

    Completed
    • Indolent Non-Hodgkin Lymphoma
    • +2 more
    • Aurora, Colorado
    • +2 more
    Mar 31, 2016